AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $9.75
- 52-wk low
- $2.76
- Prev close
- $6.45
- Mkt cap
- $2.55B
- Beta
- 1.52
- P/S
- 15.0x
Smart money
Earnings
Earnings landed in line with what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $13.1M | $41.9M | $83.2M | $31.7M |
| Cost of what it sold | $3.3M | $423.0K | $5.6M | $911.0K |
| Gross profit | $9.8M | $41.4M | $77.6M | $30.8M |
| What it spent | ||||
| Research and development | $28.8M | $34.3M | $35.0M | $30.7M |
| Sales and admin | $36.9M | $40.3M | $38.3M | $42.6M |
| Other operating costs | — | $856.0K | — | $8.6M |
| Total operating expenses | $66.2M | $75.5M | $73.7M | $81.8M |
| What was left | ||||
| Operating profit | -$56.4M | -$34.0M | $3.9M | -$51.0M |
| Interest on debt | $6.5M | $6.7M | $6.7M | $6.8M |
| Profit before tax | -$55.8M | -$36.6M | $5.4M | -$62.8M |
| Net profit | -$55.8M | -$36.6M | $5.4M | -$62.8M |
| EBITDA | -$54.8M | -$29.4M | $12.6M | -$55.5M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
1 article · 7 days
Coverage is neutral
Tone of tracked coverage
Nuvation Bio (NYSE: NUVB) posts $31.7M Q2 revenue and $62.8M loss
NeutralAug 6
